Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Pathophysiology and management of Von Hippel-Lindau syndrome

Ramaprasad Srinivasan, MD, PhD, National Cancer Institute, Bethesda, MD, provides an overview of Von Hippel-Lindau (VHL) syndrome, an inherited, autosomal recessive disorder. Patients with VHL syndrome are more likely to have malignant tumors that will metastasize. These tumors can be found in the kidneys, renal cysts, the pancreas and the central nervous system. Whilst tumors are typically treated individually via surgery, they tend to keep reoccurring. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.